Hospital Cancer Diagnostics Market : World Cancer Diagnostics Market Segmentation Analysis
Cancer is an acute disease caused by genetic malfunctions. Early diagnosis of cancer is very critical for providing accurate and effective treatment. A patient is subjected to variety of tests and exams in hospital as well as in the laboratories. Pap test was the first screening test used for detection of cancer which was promoted in the 1960s by the American Cancer Society. Significance of this test was that it helped in early diagnosis and treatment of cervical cancer leading to decline in death rate of cervical cancer patients by about 70%.
Get Free PDF Brochure for more Professional and Technical industry insights: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11501
In recent years, cancer diagnostics have evolved rapidly with introduction of new technologies and applications. Today several types of cancers are diagnosed using wide array of methods. The global market for hospital cancer diagnostics is expanding at exponential rate due to rising prevalence of cancer across the globe. Additionally, the advancement in understanding and treating cancer coupled with high awareness about the disease has heightened the demand for cancer diagnosis worldwide.
Hospital Cancer Diagnostics Market: Segmentation
The global hospital diagnostics market is segmented on the basis of type of cancer, such as breast cancer, bladder cancer, lung cancer, leukemia, lymphoma, oral cancer, skin cancer, uterine cancer, ovarian cancer, colon and rectal cancer, prostate cancer, stomach cancer, and other cancers.
The most common methods utilized for cancer diagnosis in hospital include laboratory tests (blood & urine tests), biopsy, endoscopy, diagnostic imaging, genetic tests, nuclear medicine scans (bone scans, etc.), and hematology tests. Diagnostic imaging for cancer diagnosis used several techniques like x-rays, CT (computerized tomography) and CAT (computerized axial tomography) scans, magnetic resonance imaging (MRI), ultrasound, mammography and positron emission tomography (PET) scanning.
Next generation cancer diagnostics include lab-on-a-chip, microarrays, multiplexed assays, next generation sequencing (NGS), pyro-sequencing, RT-PCR, Spectral Karyotyping (SKY), and cellular capture and identification. These technological advancements are creating favorable conditions for market growth.
Hospital Cancer Diagnostics Market: Regional Overview
Geographically, the global market for hospital cancer diagnostics is segmented into four major regions, namely, North America, Europe, Asia-Pacific and Rest of the World. The World Health Organization has highlighted the disparity in policies on early cancer detection among several countries in the world. In developed countries such as the U.S., Canada, and some major countries in European Union, cancer screening programs for detecting cancer are common and more encouraged in comparison to least developed countries. Therefore, the present market for hospital diagnostic testing is dominated in North America and Europe while the future market lied in the potential markets of Asia-Pacific region.
According to WHO report, more than 60% of world’s total new annual cases occur in Africa, Asia and Central and South America. Lack of early diagnosis caused patients to die and these regions account for approximately 70% of the global cancer deaths. Such high prevalence of cancer disease in these regions will compel governments in these nations to implement cancer screening programs.
Hospital Cancer Diagnostics Market: Key Players
Some of the major companies which provide technology platforms and diagnostic technology for cancer diagnosis include Abbott, AdnaGen AG, Applied Genetic Technologies Corporation, Beckman Coulter/Danaher Corporation, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Dako (a Agilent Technologies company), Cepheid, Inc., diaDexus, Inc., Myriad Genetics, Inc., QIAGEN N.V., Hologic Corporation, Ortho Clinical Diagnostics (a Johnson & Johnson company), F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Corporation, Sequenom, Inc. and GE Healthcare.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hospital Cancer Diagnostics Market : World Cancer Diagnostics Market Segmentation Analysis here
News-ID: 360076 • Views: 481
More Releases from Transparency Market Research
Exclusive Strategic Report on Centrifugal Fan Wheels Market to Eclipse USD 500 M …
COVID-safe Ventilation Prevents Disease Transmission in Buildings, Workplaces As coronavirus restrictions are being relaxed in countries such as China, Australia, Israel, and New Zealand, there is a need for COVID-safe ventilation at workplaces and factories as staff and other individuals return to work. Apart from focusing on essential industries including power generation, oil & gas, and steel sectors, companies in the global centrifugal fan wheels market are diversifying their products and
Future Analysis and Scope of Ammonium Sulfate Market to Drive Huge Growth betwee …
Companies Ensure Business Continuity in Fertilizer Supply during COVID-19 Pandemic Although most companies are facing a slowdown in business activities, companies in the India ammonium sulfate market such as the Fertilisers and Chemicals Travancore Limited or FACT have administered record profit despite the COVID-19 pandemic. Such findings are grabbing the attention of Indian manufacturers who are increasing efforts to ensure business continuity in fertilizer supply and additive supply. As such, third
Analysis on the Global Performance Minerals Additives Market (2020-2024) by Usag …
Mission-critical Projects in Packaging Create Business Opportunities during COVID-19 Crisis The coronavirus pandemic has affected almost all end markets, whilst not sparing the performance minerals additives market. Performance minerals additives are virtually found in all applications of construction, packaging, and automotive industries. However, the growth of these industries is affecting the performance minerals additives market. In order to stay afloat during the COVID-19 outbreak, manufacturers are focusing on essential industries such
Revenue Growth of the Cyclic Olefin Copolymers Market to be Influenced by Growin …
COC Proving Better Alternative to PC, PMMA Cyclic olefin copolymers (COC) are high-temperature polymers with exceptional optical properties, reliable chemical and heat resistance, and superior dimensional stability. Since its introduction decades ago, it has become a popularly used material in medical and packaging applications. The remarkably high purity and distinct properties of COC have made it the dominant material in advanced diagnostic and microfluidic utilization. The use of cyclic olefin copolymers
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and